A large number of studies have shown that ZIC2 is upregulated in renal cell carcinoma [15], prostate cancer [16], oral squamous cell carcinoma [17], and bladder cancer [18], in which high expression of ZIC2 is associated with a poor prognosis. The gene discussed is ZIC2; the disease is prostate cancer.